secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2026-08-20T20:19:00+00:00
Accession:  0001104659-26-099239
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin shareholders approve NED compensation increase to $250k base retainer
---------------------------------------------------------------------------

- Annual base retainer for non-employee directors increased to up to $250,000, set annually by Compensation Committee.
- Range for annual option awards raised to no less than $20,000 and no more than $200,000, at Compensation Committee discretion.
- All 7 director nominees re-elected; say-on-pay approved with 18,127,445 for votes.
- Shareholders approved 401(k) matching contribution changes and ratified CBIZ CPAs P.C. as auditor.
- Record date July 15, 2026: 70,294,615 ordinary shares outstanding; voting results include 16.3M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/0001104659-26-099239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/tm2623719d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-099239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer